Tag Archives: BCLI

Top 5 Heal Care Stocks To Own Right Now

Shares of ImmunoGen, Inc. (NASDAQ:IMGN) rose 6.6% during trading on Thursday . The stock traded as high as $11.08 and last traded at $11.04. Approximately 3,157,358 shares changed hands during trading, an increase of 3% from the average daily volume of 3,064,728 shares. The stock had previously closed at $10.36.

IMGN has been the subject of several research reports. HC Wainwright set a $18.00 price target on shares of ImmunoGen and gave the stock a “buy” rating in a report on Tuesday, April 10th. BidaskClub cut shares of ImmunoGen from a “strong-buy” rating to a “buy” rating in a report on Friday, March 30th. Canaccord Genuity restated a “buy” rating and set a $20.00 price target on shares of ImmunoGen in a report on Friday, April 27th. Finally, ValuEngine cut shares of ImmunoGen from a “strong-buy” rating to a “buy” rating in a report on Friday, June 8th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $12.42.

Top 5 Heal Care Stocks To Own Right Now: Neometals Ltd (RRSSF)

Neometals Ltd is a mineral project developer. The Companys segments include Lithium, Titanium and Vanadium, and Others. The Companys projects include Mount Marion Lithium Project, Lithium Hydroxide Project (ELi Process), Alphamet, Barrambie Titanium Vanadium Iron Project (Barrambie Titanium) and Forrestania Nickel Project. The Company’s Mount Marion Lithium Project is located approximately 40 kilometers southwest of Kalgoorlie, Western Australia. The Company is also focused on the Mount Finnerty Project, which is located approximately 60 kilometers east of Koolyannobbing. The ELi Process has been jointly developed by the Company and Mineral Resources Limited. The Companys Barrambie Titanium project uses a technology to manage titanium, vanadium and iron compounds. The Companys Forrestania Nickel Project is located approximately seven kilometers north of the flying fox nickel sulfide mine in the Yilgarn region of Western Australia. Advisors’ Opinion:

  • [By ]

    Neometals [ASX:NMT] (OTCPK:RDRUY) (OTCPK:RRSSF)

    Neometals is primarily a lithium producer however they 100% own the Barrambie Titanium Vanadium Iron Project in Western Australia. Barrambie’s Eastern Band is one of the highest grade hard rock titanium deposits globally.

  • [By ]

    Jiangxi Ganfeng Lithium [SHE:002460], Mineral Resources [ASX:MIN] (OTCPK:MALRY), Neometals (OTC:RRSSF) (Nasdaq:RDRUY) [ASX:NMT], International Lithium Corp. [TSXV:ILC] (OTCPK:ILHMF)

  • [By SEEKINGALPHA.COM]

    Neometals [ASX:NMT] [GR:9R9](OTC:RRSSF)

    Neometals is primarily a lithium mining company in Western Australia. They own a 13.8% share of the Mt Marion lithium spodumene producing mine. The company has plans to develop a Kalgoorlie lithium hydroxide facility. You can read more on that here. The company also has the world’s second highest titanium resource, and some vanadium.

Top 5 Heal Care Stocks To Own Right Now: CTI BioPharma Corp.(CTIC)

We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and health care providers. Our goal is to build a profitable company by generating income from products we develop and commercialize, either alone or with partners. We are currently concentrating our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are primarily focused on commercializing PIXUVRI in select countries in the European Union, or the E.U., for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma, or NHL, and evaluating pacritinib for the treatment of adult patients with myelofibrosis.
PIXUVRI
PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties.   Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CTI BioPharma (CTIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Steve Symington]

    Nevertheless, several individual stocks failed to keep up. Read on to see why CTI BioPharma (NASDAQ:CTIC), PetMed Express (NASDAQ:PETS), andPfizer (NYSE:PFE)each slumped today.

  • [By Brian Feroldi]

    In response to the company sharing a clinical update, shares of CTI BioPharma (NASDAQ:CTIC), a clinical-stage biotech focused on blood-related cancers, fell 13% as of 12:05 p.m. EDT on Monday.

Top 5 Heal Care Stocks To Own Right Now: Dave & Buster's Entertainment, Inc.(PLAY)

References to the “Company,” “we,” “us,” “our” and “Dave & Buster’s” in this Annual Report on Form 10-K (the “Report”) are references to Dave & Buster’s Entertainment, Inc. (“D&B Entertainment”) and its subsidiaries.
We are a leading owner and operator of high-volume entertainment and dining venues under the name “Dave & Buster’s”. The core of our concept is to offer our customers the opportunity to “Eat Drink Play and Watch” all in one location. Eat and Drink is offered through a full menu of “Fun American New Gourmet” entr茅es and appetizers and a full selection of non-alcoholic and alcoholic beverages. Our Play and Watch offerings provide an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. Our customer mix skews moderately to males, primarily between the ages of 21 and 39, and we believe we also serve as an attractive venue for families with children and teenagers.   Advisors’ Opinion:

  • [By Garrett Baldwin]

    SIT THIS ONE OUT and you could miss an American economic revolution that could send three little pot stocks soaring up to 1,000%. Click here to see why…

    Netflix Inc. (NASDAQ: NFLX) is in the middle of a big battle between the U.S. Department of Justice (DOJ) and the Motion Picture Academy. According to the letter, the DOJ is concerned about a recent rule change by the MPA that requires films to be released more widely in traditional movie theaters to qualify for Academy Awards. This could limit the participation in these awards for companies like Netflix, Hulu, and Amazon.com Inc. (NASDAQ: AMZN). The DOJ suggests the rule may raise anti-trust concerns in the future. Shares of Dave & Buster’s Entertainment Inc.(NASDAQ: PLAY) popped more than 7.5% after the restaurant and gaming chain topped Wall Street earnings expectations. The firm beat both top- and bottom-line revenue expectations and reported a big jump in same-store sales. Today, look for more earnings reports from Acuity Brands Inc. (NYSE: AYI) andSignet Jewelers Ltd.(NYSE: SIG).
    These 3 Stocks Are the Key to 2019’s Greatest Profits

    The 2018 midterm election was a turning point for the cannabis industry.

  • [By Garrett Baldwin]

    5G Is Coming: The tech breakthrough of the century could rest on this $6 stock – get all the details here.

    Investors in Lyft Inc.(NASDAQ: LYFT) are fuming after the price of the ride-sharing giant’s stock fell below the launch price of $72. Shares plunged almost 12% Monday, and they’re now off sharply from the high of $86 that we saw on the first day of trading. Some Wall Street analysts suggest the fall in price is a signal that valuations of Unicorn companies like Lyft and Uber are too lofty in today’s market. Today, we have to take a victory lap since we warned investors to avoid the Lyft IPO. Amazon.com Inc. (NASDAQ: AMZN) is about to make things far more difficult for its grocery store competition. In an effort to jump-start sales at Whole Foods, Amazon plans to slash prices Wednesday on more than 500 products, including produce and meat. Look for earnings reports from Dave & Buster’s Entertainment Inc. (NASDAQ: PLAY), NovaGold Resources Inc. (NYSE: DG), and GameStop Corp. (NYSE: GME).
    5G Is Coming: The Breakthrough of the Century Could Rest on This $6 Stock

    CNBC reports that this opportunity is worth $12.3 trillion… and it’s gearing up to make an appearance all over America.

  • [By Motley Fool Transcribing]

    Dave & Buster’s Entertainment (NASDAQ:PLAY) Q4 2018 Earnings Conference CallApril 2, 2019 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Motley Fool Transcribers]

    Dave & Buster’s Entertainment Inc (NASDAQ:PLAY)Q42018 Earnings Conference CallApril 02, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Heal Care Stocks To Own Right Now: Brainstorm Cell Therapeutics Inc.(BCLI)

We are a biotechnology company developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (“ALS”, also known as Lou Gehrig’s disease), Multiple Sclerosis (“MS”), and Parkinson’s disease (“PD”) among others. These diseases for the most part have no or limited treatment options and as such represent unmet medical needs. We believe that NurOwn庐, our proprietary process for the propagation of Mesenchymal Stem Cells (“MSC”) and their differentiation into neurotrophic factor-(“NTF”) secreting cells (“MSC-NTF”), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases. Our core technology was developed in collaboration with Prof. Daniel Offen of the Felsenstein Medical Research Center of Tel Aviv University and the late Prof.   Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Brainstorm Cell Therapeutics (BCLI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    News stories about Brainstorm Cell Therapeutics (NASDAQ:BCLI) have been trending somewhat positive recently, Accern Sentiment reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Brainstorm Cell Therapeutics earned a coverage optimism score of 0.13 on Accern’s scale. Accern also assigned press coverage about the biotechnology company an impact score of 46.7813662313817 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top 5 Heal Care Stocks To Own Right Now: Primero Mining Corp(PPP)

Primero Mining Corp. is a precious metals producer with operations in both Mexico and Canada. The Company is focused on building a portfolio of precious metals assets in the Americas through acquiring, exploring, developing and operating mineral resource properties. Its segments include San Dimas, Cerro del Gallo, Black Fox Complex and Corporate. It owns over two producing properties, including the San Dimas gold-silver mine, located in Mexico’s San Dimas district, and the Black Fox mine, located in the Township of Black River-Matheson, Ontario, Canada. It owns properties adjacent to the Black Fox mine, Grey Fox and Pike River, which together with the Black Fox mine and the Black Fox mill, located on the Stock Mill property, comprise the Black Fox Complex. It also owns over two exploration properties, including the Cerro del Gallo gold-silver-copper project, which is located in the state of Guanajuato in central Mexico, and Ventanas, which is located in Durango State, Mexico. Advisors’ Opinion:

  • [By Max Byerly]

    PayPie (CURRENCY:PPP) traded 1.5% lower against the dollar during the 1-day period ending at 14:00 PM E.T. on July 22nd. In the last week, PayPie has traded 2.7% lower against the dollar. One PayPie token can currently be bought for $0.24 or 0.00003163 BTC on exchanges including Fatbtc and EtherDelta (ForkDelta). PayPie has a market capitalization of $19.55 million and approximately $19,027.00 worth of PayPie was traded on exchanges in the last day.

  • [By Shane Hupp]

    PayPie (CURRENCY:PPP) traded 5.6% lower against the U.S. dollar during the 1-day period ending at 20:00 PM Eastern on June 20th. During the last week, PayPie has traded down 2.7% against the U.S. dollar. One PayPie token can currently be purchased for about $0.32 or 0.00004751 BTC on major exchanges including Fatbtc and EtherDelta (ForkDelta). PayPie has a total market cap of $26.47 million and $29,238.00 worth of PayPie was traded on exchanges in the last day.

Top 5 Heal Care Stocks To Invest In 2019

Kraton (NYSE: KRA) and Eastman Chemical (NYSE:EMN) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Dividends

Get Kraton alerts:

Eastman Chemical pays an annual dividend of $2.24 per share and has a dividend yield of 2.1%. Kraton does not pay a dividend. Eastman Chemical pays out 29.4% of its earnings in the form of a dividend. Eastman Chemical has raised its dividend for 6 consecutive years.

Institutional and Insider Ownership

97.3% of Kraton shares are held by institutional investors. Comparatively, 83.9% of Eastman Chemical shares are held by institutional investors. 4.7% of Kraton shares are held by insiders. Comparatively, 1.1% of Eastman Chemical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Top 5 Heal Care Stocks To Invest In 2019: Ascendis Pharma A/S(ASND)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ascendis Pharma (ASND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Ascendis Pharma A/S (NASDAQ: ASND) is expected to present full Phase 1 data from its TransCon-PTH hypoparathyroidism treatment later this month. Shares of Ascendis closed Friday at $66.52, with a consensus analyst target price of $84.66 and a 52-week trading range of $25.50 to $76.29.

  • [By Chris Lange]

    Ascendis Pharma A/S (NASDAQ: ASND) is expected to present full Phase 1 data from its TransCon-PTH hypoparathyroidism treatment later this month. Shares of Ascendis closed Friday at $66.78, with a consensus analyst target of $80.17 and a 52-week range of $22.25 to $76.29.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Ascendis Pharma A/S (ASND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Ascendis Pharma (NASDAQ:ASND) saw some unusual options trading activity on Monday. Investors purchased 1,979 call options on the stock. This is an increase of approximately 1,377% compared to the typical volume of 134 call options.

  • [By ]

    There was also a mixed bag of other suggestions — Rashmi Kwatra, the founder of Sixteenth Street Capital, liked Brac Bank, which is listed on the Dhaka stock market in Bangladesh. It is the 12th largest bank in Bangladesh, but the most profitable with the highest credit rating. John Khoury of Long Point Capital LP sees a 50% upside at homebuilder D.R. Horton (DHI)  and Oleg Nodelman likes U.S. biotech firm Ascendis Pharma. (ASND)

Top 5 Heal Care Stocks To Invest In 2019: Brainstorm Cell Therapeutics Inc.(BCLI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Axovant Sciences Ltd. (NASDAQ: AXON) shares rose 23.7 percent to $1.49. Axovant announced strengthening of management team and completion of organization restructuring which "enhanced capabilities in research and business development" and reduced internal headcount by 43 percent.
    Mammoth Energy Services, Inc. (NASDAQ: TUSK) shares jumped 19.8 percent to $37.3148. Mammoth Energy’s subsidiary Cobra signed a new $900 million contract to finish the restoration of critical electrical services and support the initial phase of reconstruction of the electrical utility system in Puerto Rico.
    Acorn International, Inc. (NYSE: ATV) shares gained 19 percent to $34.0201. Acorn shares rose Friday after the company declared a special one-time cash dividend of $14.97 per ADS.
    DHI Group, Inc. (NYSE: DHX) shares surged 19 percent to $2.20.
    My Size, Inc. (NASDAQ: MYSZ) climbed 16.8 percent to $1.18 after the company received a Notice of Allowance from the USPTO for measurement technology patent.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) gained 16.6 percent to $2.32.
    Leju Holdings Limited (NYSE: LEJU) gained 16.5 percent to $1.34 following Q1 beat.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16.5 percent to $26.1499. Evolus named Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development.
    Jupai Holdings Limited (NYSE: JP) shares gained 15 percent to $26.29 after reporting Q1 results.
    Momo Inc. (NASDAQ: MOMO) shares gained 15 percent to $44.7702 after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Windstream Holdings, Inc. (NASDAQ: WIN) rose 15 percent to $7.075.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) gained 14.4 percent to $2.746.
    American Woodmark Corporation (NASDAQ: AMWD) climbed 14.2 percent to $101.10 after the company reported upbeat Q4 results.
    Savara Inc. (NAS
  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

  • [By Stephan Byrd]

    Brainstorm Cell Therapeutics (NASDAQ:BCLI) is scheduled to announce its earnings results before the market opens on Monday, July 23rd.

    Brainstorm Cell Therapeutics (NASDAQ:BCLI) last announced its earnings results on Monday, May 14th. The biotechnology company reported ($0.12) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.02. On average, analysts expect Brainstorm Cell Therapeutics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

  • [By Logan Wallace]

    Maxim Group set a $9.00 target price on Brainstorm Cell Therapeutics (NASDAQ:BCLI) in a research note issued to investors on Monday morning. The brokerage currently has a buy rating on the biotechnology company’s stock.

Top 5 Heal Care Stocks To Invest In 2019: Jupai Holdings Limited(JP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
    Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
    DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
    Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
    Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
    Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
    Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
    Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
    Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    Axovant Sciences Ltd. (NASDAQ: AXON) shares rose 23.7 percent to $1.49. Axovant announced strengthening of management team and completion of organization restructuring which "enhanced capabilities in research and business development" and reduced internal headcount by 43 percent.
    Mammoth Energy Services, Inc. (NASDAQ: TUSK) shares jumped 19.8 percent to $37.3148. Mammoth Energy’s subsidiary Cobra signed a new $900 million contract to finish the restoration of critical electrical services and support the initial phase of reconstruction of the electrical utility system in Puerto Rico.
    Acorn International, Inc. (NYSE: ATV) shares gained 19 percent to $34.0201. Acorn shares rose Friday after the company declared a special one-time cash dividend of $14.97 per ADS.
    DHI Group, Inc. (NYSE: DHX) shares surged 19 percent to $2.20.
    My Size, Inc. (NASDAQ: MYSZ) climbed 16.8 percent to $1.18 after the company received a Notice of Allowance from the USPTO for measurement technology patent.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) gained 16.6 percent to $2.32.
    Leju Holdings Limited (NYSE: LEJU) gained 16.5 percent to $1.34 following Q1 beat.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16.5 percent to $26.1499. Evolus named Lauren Silvernail as Chief Financial Officer and Executive Vice President, Corporate Development.
    Jupai Holdings Limited (NYSE: JP) shares gained 15 percent to $26.29 after reporting Q1 results.
    Momo Inc. (NASDAQ: MOMO) shares gained 15 percent to $44.7702 after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Windstream Holdings, Inc. (NASDAQ: WIN) rose 15 percent to $7.075.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) gained 14.4 percent to $2.746.
    American Woodmark Corporation (NASDAQ: AMWD) climbed 14.2 percent to $101.10 after the company reported upbeat Q4 results.
    Savara Inc. (NAS
  • [By Lisa Levin]

    Jupai Holdings Limited (NYSE: JP) shares shot up 16 percent to $26.48 after reporting Q1 results.

    Shares of American Woodmark Corporation (NASDAQ: AMWD) got a boost, shooting up 13 percent to $100.05 after the company reported upbeat Q4 results.

  • [By Lisa Levin]

    On Tuesday, the financial shares surged 0.71 percent. Meanwhile, top gainers in the sector included Guaranty Bancorp (NASDAQ: GBNK), up 5 percent, and Jupai Holdings Limited (NYSE: JP) up 5 percent.

Top 5 Heal Care Stocks To Invest In 2019: Nuveen Massachusetts Premium Income Municipal Fund(NMT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News articles about Nuveen Massachusetts Pre Income Mun Fd (NYSE:NMT) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Nuveen Massachusetts Pre Income Mun Fd earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the financial services provider an impact score of 47.5987310031013 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 5 Heal Care Stocks To Invest In 2019: Farmers National Banc Corp.(FMNB)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Farmers National Banc (NASDAQ:FMNB)‘s stock had its “hold” rating reissued by equities researchers at Keefe, Bruyette & Woods in a note issued to investors on Thursday. They presently have a $18.00 price target on the bank’s stock. Keefe, Bruyette & Woods’ price target would indicate a potential upside of 21.62% from the company’s previous close.

Hot China Stocks To Own For 2019

While a U.S.-China trade war “wouldn’t be good for anyone,” according to Alibaba’s executive vice chairman and co-founder, it wouldn’t be particularly painful for Chinese e-commerce giant Alibaba Group Holding Ltd.  (BABA) , either.

“You could view Alibaba as a very large platform for producers from all around the world to access Chinese consumers,” said Joseph Tsai on Alibaba’s fiscal fourth-quarter earnings call Friday, May 4, in response to a question from an analyst. Tsai noted that Alibaba currently has 550 million annual active shoppers in China.

“Now, the trade war right now is really just between the United States and China, so it’s really limited to that trade flow,” Tsai said. “So when Chinese consumers look abroad to buy things from overseas, there could be replacements.”

Hot China Stocks To Own For 2019: Brainstorm Cell Therapeutics Inc.(BCLI)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

    Get Brainstorm Cell Therapeutics alerts:

    Brainstorm Cell Therapeutics (BCLI) Issues Quarterly Earnings Results, Beats Expectations By $0.20 EPS (americanbankingnews.com) BrainStorm Announces First Quarter 2018 Financial Results and Provides Corporate and Clinical Highlights (finance.yahoo.com) What analyst predict for Brainstorm Cell Therapeutics NASDAQ:BCLI ? (stockmarketdaily.co) Global Autologous Cell Therapy Market 2022: Market Size, Shares, Revenue, Production, Consumption (thetechnicalprogress.com) Hot Stocks to Observe: Forward Industries, Inc. (NASDAQ:FORD), Nordic American Tankers Limited (NYSE:NAT … (journalfinance.net)

    Shares of Brainstorm Cell Therapeutics traded up $0.12, hitting $3.76, during trading hours on Monday, according to MarketBeat. 1,552 shares of the stock were exchanged, compared to its average volume of 63,674. The company has a market cap of $69.42 million, a P/E ratio of -14.46 and a beta of 1.86. Brainstorm Cell Therapeutics has a one year low of $3.70 and a one year high of $3.85.

  • [By Logan Wallace]

    Maxim Group set a $9.00 target price on Brainstorm Cell Therapeutics (NASDAQ:BCLI) in a research note issued to investors on Monday morning. The brokerage currently has a buy rating on the biotechnology company’s stock.

Hot China Stocks To Own For 2019: (LGEAF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Coherent’s ELA deposition technology for LTPS backplane isn’t used in OLED TVs, where LG (OTC:LGEAF) uses metal oxide backpanes. There was some worry by analysts whether that technology could migrate to the smartphone panel market which CEO Ambroseo could not dispel entirely, but he argued that it has not been demonstrated suitable for handsets or battery-powered devices at this point.

Hot China Stocks To Own For 2019: AtriCure Inc.(ATRC)

Advisors’ Opinion:

  • [By Shane Hupp]

    ValuEngine upgraded shares of AtriCure (NASDAQ:ATRC) from a hold rating to a buy rating in a research report report published on Saturday.

    A number of other research firms have also weighed in on ATRC. Zacks Investment Research lowered shares of AtriCure from a buy rating to a hold rating in a report on Wednesday, May 2nd. BidaskClub raised shares of AtriCure from a hold rating to a buy rating in a report on Saturday, March 17th. Stifel Nicolaus raised their target price on shares of AtriCure from $22.00 to $23.00 and gave the company a buy rating in a report on Friday, April 27th. Needham & Company LLC raised their target price on shares of AtriCure from $23.00 to $26.00 and gave the company a buy rating in a report on Friday, April 27th. Finally, TheStreet raised shares of AtriCure from a d+ rating to a c- rating in a report on Friday, March 16th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of Buy and an average target price of $25.00.

Hot China Stocks To Own For 2019: Flanigan’s Enterprises Inc.(BDL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Best Gold Stocks To Own For 2018

What happened

Shares of Kinross Gold Corporation (NYSE:KGC) fell 14.3% today after the company announced first-quarter 2018 results. While the company delivered top-line growth compared to the year-ago period thanks to higher sales volumes and selling prices, it didn’t trickle down to the bottom line. Instead, net income actually decreased 21% compared to the performance in the first quarter of 2017. It’s the same sticking point Wall Street had with full-year 2017 results.

Turns out, nearly all of the decrease could be explained away by a higher income tax burden. All other important financial metrics — including all-in sustaining cost (AISC) per gold equivalent ounce, operating income, and operating cash flow — improved in the year-over-year comparison.

As of 1:01 p.m. EDT, the stock had settled to a 12.1% loss.

Image source: Getty Images.

Best Gold Stocks To Own For 2018: Evoke Pharma, Inc.(EVOK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Evoke Pharma (EVOK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Gold Stocks To Own For 2018: UMH Properties Inc.(UMH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, the real estate shares surged 0.56 percent. Meanwhile, top gainers in the sector included Armada Hoffler Properties, Inc. (NYSE: AHH), up 3 percent, and UMH Properties, Inc. (NYSE: UMH) up 3 percent.

Best Gold Stocks To Own For 2018: Neo Lithium Corp. (NTTHF)

Advisors’ Opinion:

  • [By ]

    The following 6 companies are on the bench for the index:

    Advantage Lithium (OTCQX:AVLIF) Argosy Minerals (OTCPK:ARYMF) Bacanora Minerals (OTC:BCRMF) Critical Elements (OTCQX:CRECF) NEO Lithium (OTCQX:NTTHF) Wealth Minerals (OTCQX:WMLLF)

    “Bench” is a sports analogy meaning that one or more of them could be added in the future if one of the above companies becomes a producer, is acquired, or the market capitalization (“cap”) of one or more of the index holdings falls significantly below that of one or more companies on the bench.

Best Gold Stocks To Own For 2018: Luna Innovations Incorporated(LUNA)

Advisors’ Opinion:

  • [By Logan Wallace]

    PRA Health Sciences (NASDAQ: PRAH) and Luna Innovations (NASDAQ:LUNA) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Luna Innovations (LUNA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Gold Stocks To Own For 2018: Financial Institutions Inc.(FISI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Financial Institutions (FISI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Gold Stocks To Own For 2018: Brainstorm Cell Therapeutics Inc.(BCLI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

  • [By Logan Wallace]

    Maxim Group set a $9.00 target price on Brainstorm Cell Therapeutics (NASDAQ:BCLI) in a research note issued to investors on Monday morning. The brokerage currently has a buy rating on the biotechnology company’s stock.

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

    Get Brainstorm Cell Therapeutics alerts:

    Brainstorm Cell Therapeutics (BCLI) Issues Quarterly Earnings Results, Beats Expectations By $0.20 EPS (americanbankingnews.com) BrainStorm Announces First Quarter 2018 Financial Results and Provides Corporate and Clinical Highlights (finance.yahoo.com) What analyst predict for Brainstorm Cell Therapeutics NASDAQ:BCLI ? (stockmarketdaily.co) Global Autologous Cell Therapy Market 2022: Market Size, Shares, Revenue, Production, Consumption (thetechnicalprogress.com) Hot Stocks to Observe: Forward Industries, Inc. (NASDAQ:FORD), Nordic American Tankers Limited (NYSE:NAT … (journalfinance.net)

    Shares of Brainstorm Cell Therapeutics traded up $0.12, hitting $3.76, during trading hours on Monday, according to MarketBeat. 1,552 shares of the stock were exchanged, compared to its average volume of 63,674. The company has a market cap of $69.42 million, a P/E ratio of -14.46 and a beta of 1.86. Brainstorm Cell Therapeutics has a one year low of $3.70 and a one year high of $3.85.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

Best Undervalued Stocks For 2018

I hate getting distracted by the thousands of other stocks out there. Because then things like GameStop Corp. (NYSE:GME) becoming an 8% yielding dividend stock — it may also be undervalued — happen.

GME stock has had a dizzying ride over the past 15 years, starting at $10 per share and reaching $62 at its peak in 2007, hitting a low of $16 in 2012, riding back up to $53 in 2013 and now sitting at $19 and falling. It has struggled because it has had to constantly morph to keep up with changes in gaming technology and platforms, and with competition. That has in turn required it to pivot and diversify into other offerings that have seen some limited success.

The gaming world is constantly in flux. That requires GME to hire employees who are able to be on the front lines of all the changes. Because GME stock derives a lot of revenues from its pre-owned game sales, employees must be experts in the areas of buy-sell-trade, pricing algorithms, inventory balancing, refurbishment capability, and consumer behavior.

Best Undervalued Stocks For 2018: Cambium Learning Group Inc.(ABCD)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Cambium Learning Group (NASDAQ:ABCD) Q1 2018 Earnings Conference CallMay. 14, 2018 9:00 a.m. ET

    Contents:
    Prepared Remarks Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 78.82 percent to close at $7.26 on Monday.
    GEE Group, Inc. (NYSE: JOB) shares jumped 18 percent to close at $2.36.
    McDermott International, Inc. (NYSE: MDR) climbed 15.7 percent to close at $7.00 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) gained 17.21 percent to close at $3.61.
    Stars Group Inc. (NASDAQ: TSG) rose 14.16 percent to close at $33.45. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares jumped 12.79 percent to close at $25.58.
    Nautilus, Inc. (NYSE: NLS) shares gained 11.52 percent to close at $15.00. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target.
    Box, Inc. (NYSE: BOX) rose 10.94 percent to close at $22.91.
    Insmed Incorporated (NASDAQ: INSM) shares rose 10.76 percent to close at $26.05. Credit Suisse upgraded Insmed from Neutral to Outperform.
    NextDecade Corporation (NASDAQ: NEXT) shares rose 10.02 percent to close at $6.48.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) shares gained 8.37 percent to close at $2.46 on Monday after falling 10.98 percent on Friday.
    Cambium Learning Group, Inc. (NASDAQ: ABCD) shares gained 7.81 percent to close at $11.11.
    Vectren Corporation (NYSE: VVC) shares rose 7.26 percent to close at $70.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash.
    Tennant Company (NYSE: TNC) rose 6.66 percent to close at $74.45 after the company posted upbeat Q1 results and raised its FY18 earnings outlook.
    Hanesbrands Inc.
  • [By Logan Wallace]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Cambium Learning Group alerts:

    WMMS teacher up for National History Day award (dailyprogress.com) ValuEngine Upgrades Cambium Learning Group (ABCD) to Buy (americanbankingnews.com) John F. Campbell Sells 20,809 Shares of Cambium Learning Group (ABCD) Stock (americanbankingnews.com) Cambium Learning Group to Announce First Quarter 2018 Financial Results (feeds.benzinga.com)

    Several brokerages have commented on ABCD. BidaskClub raised Cambium Learning Group from a “hold” rating to a “buy” rating in a research report on Saturday, January 13th. ValuEngine raised Cambium Learning Group from a “hold” rating to a “buy” rating in a research report on Wednesday, May 2nd. Finally, B. Riley assumed coverage on Cambium Learning Group in a research report on Thursday, March 29th. They issued a “buy” rating and a $12.50 price target for the company.

  • [By Lisa Levin] Gainers
    Valeritas Holdings, Inc. (NASDAQ: VLRX) shares jumped 17 percent to $3.65.
    Cambium Learning Group, Inc. (NASDAQ: ABCD) shares rose 13.5 percent to $11.70.
    McDermott International, Inc. (NYSE: MDR) gained 11.6 percent to $6.75 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.
    Nautilus, Inc. (NYSE: NLS) shares jumped 11.2 percent to $14.95. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target.
    GEE Group, Inc. (NYSE: JOB) shares gained 11 percent to $2.2199.
    Check-Cap Ltd. (NASDAQ: CHEK) surged 10.8 percent to $4.50.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) rose 10.1 percent to $3.39.
    Stars Group Inc. (NASDAQ: TSG) climbed 9.6 percent to $32.10. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion.
    Insmed Incorporated (NASDAQ: INSM) shares jumped 9.1 percent to $25.66. Credit Suisse upgraded Insmed from Neutral to Outperform.
    Tennant Company (NYSE: TNC) rose 8.4 percent to $75.65 after the company posted upbeat Q1 results and raised its FY18 earnings outlook.
    Command Security Corporation (NYSE: MOC) shares gained 6.4 percent to $3.0960 after the company disclosed a $23 million five-year contract with LaGuardia Gateway Partners for LaGuardia Airport New Central Terminal Building.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 6.2 percent to $2.41 after falling 10.98 percent on Friday.
    Vectren Corporation (NYSE: VVC) shares rose 5.7 percent to $69.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash.
    Hanesbrands Inc. (NYSE: HBI) gained 4.9 percent to $18.035. Stifel Nicolaus upgraded Hanesbrands from Hold to Buy.
    M

Best Undervalued Stocks For 2018: Brainstorm Cell Therapeutics Inc.(BCLI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

    Get Brainstorm Cell Therapeutics alerts:

    Brainstorm Cell Therapeutics (BCLI) Issues Quarterly Earnings Results, Beats Expectations By $0.20 EPS (americanbankingnews.com) BrainStorm Announces First Quarter 2018 Financial Results and Provides Corporate and Clinical Highlights (finance.yahoo.com) What analyst predict for Brainstorm Cell Therapeutics NASDAQ:BCLI ? (stockmarketdaily.co) Global Autologous Cell Therapy Market 2022: Market Size, Shares, Revenue, Production, Consumption (thetechnicalprogress.com) Hot Stocks to Observe: Forward Industries, Inc. (NASDAQ:FORD), Nordic American Tankers Limited (NYSE:NAT … (journalfinance.net)

    Shares of Brainstorm Cell Therapeutics traded up $0.12, hitting $3.76, during trading hours on Monday, according to MarketBeat. 1,552 shares of the stock were exchanged, compared to its average volume of 63,674. The company has a market cap of $69.42 million, a P/E ratio of -14.46 and a beta of 1.86. Brainstorm Cell Therapeutics has a one year low of $3.70 and a one year high of $3.85.

Best Undervalued Stocks For 2018: General Growth Properties, Inc.(GGP)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Shares of mall-focused REIT GGP (NYSE:GGP) have plunged in 2018. Initially, the stock price fell due to ongoing worries about the so-called “retail apocalypse” and its effect on mall occupancy and lease rates.

  • [By Adam Levine-Weinberg]

    In recent years, investors have become increasingly fearful about the so-called “death of the mall.” As a result, shares of top-tier mall REITs like Taubman Centers (NYSE:TCO), Simon Property Group (NYSE:SPG), GGP (NYSE:GGP), and Macerich (NYSE:MAC) have tended to trade at a discount to their net asset values (NAV), the underlying value of their assets.

  • [By Joseph Griffin]

    These are some of the news articles that may have effected Accern’s scoring:

    Get GGP alerts:

    Read This Before Trade: Facebook, Inc. (FB), GGP Inc. (GGP) (nmsunews.com) Ggp Inc (GGP)’s Weekly Performance of -0.90% Is Nothing to Write Home About (parkcitycaller.com) Is GGP Inc (NYSE:GGP) A Good Dividend Stock? (finance.yahoo.com) GGP (GGP) Downgraded by Zacks Investment Research to “Hold” (americanbankingnews.com) Dazzling Stocks: GGP Inc. (NYSE:GGP), Nielsen Holdings plc (NYSE:NLSN), AmerisourceBergen Corporation (NYSE … (thestreetpoint.com)

    GGP has been the subject of a number of recent research reports. Royal Bank of Canada restated a “buy” rating and set a $24.00 target price on shares of GGP in a research report on Monday, February 12th. Boenning Scattergood reissued a “buy” rating and issued a $35.00 target price on shares of GGP in a research note on Tuesday, March 27th. Mizuho raised GGP from a “neutral” rating to a “buy” rating and set a $24.00 target price for the company in a research note on Monday, March 19th. Zacks Investment Research upgraded GGP from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a report on Wednesday, April 11th. Finally, Barclays cut their price target on GGP from $24.00 to $23.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 30th. Three analysts have rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company’s stock. GGP currently has an average rating of “Hold” and a consensus price target of $24.92.